Coltene Holding AG operates within the Dental equipment and supplies sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Coltene Holding AG with three other
medical equipment manufacturers in Europe:
IVF Hartmann Holding AG
sales of 134.69 million Swiss Francs [US$138.86 million]
of which 33%
was Infections Management),
Avon Rubber p.l.c.
of the United Kingdom
(£142.88 million [US$181.79 million]
of which 71%
was Protection and Defence), and
Stratec Biomedical AG
based in Germany
(184.91 million Euro [US$207.07 million]
of which 75%
During the year ended December of 2016, sales at
Coltene Holding AG were 160.67 million Swiss Francs (US$165.63 million).
increase of 4.0%
versus 2015, when the company's sales were 154.50 million Swiss Francs.
Despite this increase, sales are still
below the level achieved in 2014, when Coltene Holding AG
reported sales of 162.35 million Swiss Francs.
The sales level in 2016 was fairly close to the level five years ago: in 2011, Coltene Holding AG had sales
of 146.13 million Swiss Francs.
Sales of Prosthetics saw an increase
that was more than double the company's growth rate: sales were up
8.5% in 2016, from
31.05 million Swiss Francs to 33.68 million Swiss Francs.
Coltene Holding AG also saw significant increases in sales in
Infection Control (up 5.2% to 11.08 million Swiss Francs)
Not all segments of Coltene Holding AG experienced an increase in sales in 2016:
sales of Miscellaneous fell 8.3% to 2.48 million Swiss Francs.
(However, this segment's sales were only a very small portion of the company's overall sales).
Coltene Holding AG also experienced decreases in sales in
Laboratory (down 1.1% to 6.73 million Swiss Francs)